Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Recent News
Dr. Silverman received his MD from Harvard Medical School in 1991 and training in pediatrics at Boston Children's Hospital in 1994. He subsequently completed a fellowship in pediatric hematology-oncology at Boston Children's Hospital and Dana-Farber Cancer Institute. In 1997, he became an attending physician in pediatric hematology-oncology at Dana-Farber/Boston Children's, and today, he is Vice Chair of Clinical Affairs, Department of Pediatric Oncology, at Dana-Farber Cancer Institute and Associate Chief, Pediatric Oncology, at Boston Children's Hospital. Dr. Silverman also leads the DFCI/ALL Consortium, which conducts multi-institutional clinical trials for children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Dana-Farber Cancer Institute450 Brookline AvenueShields Warren 320Boston, MA 02215Get Directions